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Contamination of inanimate surfaces contribute to the transmission of healthcare-25 
associated infection which is well documented for methicillin-resistant Staphylococcus aureus 26 
(MRSA) and vancomycin-resistant enterococci VRE (3, 5, 10).  The high rate of skin 27 
colonisation with these bacteria among healthcare workers increases the risk of cross-28 
contamination of high-touch surfaces (6). Since Gram-negative bacteria survive poorly on 29 
surfaces, their role in transmission of infection has not been as widely investigated. Extended 30 
spectrum beta-lactamase-producing enterobacteriaciae (ESBL-PE) are now widespread and 31 
endemic in nosocomial settings (2, 4) and given the increasing prevalence of infections involving 32 
ESBL-PE, the role of the environment in ESBL-PE transmission should be explored.  This study 33 
reports the evaluation of two ESBL-PE recovery methods from typical hospital surface materials 34 
and their application for recovery of ESBL-PE adjacent to an ESBL-positive patient. 35 
Recovery methods were optimized and evaluated first in the laboratory by determining 36 
the limit of detection (LoD) when serially diluted suspensions of E. coli; ATCC 35218, K. 37 
pneumoniae; ATCC 700603 or NCTC 13465 were applied to representative hospital 38 
environment surfaces (i.e. mattress section, polished steel, formica).  Recovery was achieved using 39 
contact plates of Brilliance UTI (Oxoid, UK) supplemented with 1 g/ml cefotaxime. Plates 40 
were incubated at 37
o
C for 16-20h and bacteria were presumptively identified based on colony 41 
colour on Brilliance UTI (e.g. E. coli, pink, Klebsiella, dark blue). This method demonstrated the 42 
recovery of all strains tested, up to 1.5h (steel) and 2h (mattress and formica), following  43 
contamination but no recovery at 2.5h. The LoD, defined as the lowest number of colony forming 44 
units (cfu) applied per cm
2
 that allowed recovery of viable ESBL-PE, was 5.6 cfu/cm2 (mattress 45 
and formica) and 44 cfu/ml (steel). Recovery rates, based on the approximate surface area screened, 46 
were low and highly variable (2.1, 4.2, 5.5 % for each surface respectively). A swab method was 47 
evaluated for mattress sections only. Swabs (Copan SRK, Brescia, Italy) were pre-moistened in 48 
recovery diluent before sampling the contaminated surface and returned to the sample diluent for 49 
20 min. The swabs were sub-cultured to Brilliance ESBL agar plates (Oxoid, UK) and incubated 50 
as for contact plates. The LoD for this method was 5.6 cfu/ml. 51 
  Following laboratory evaluation of the recovery methods, they were applied in the hospital 52 
environment. Four high-touch surfaces adjacent to three ESBL-positive patients (bed handrail 53 
(steel), mattress cover, bedside locker (formica) and bedside light switch) and two sites in  54 
shared bathrooms (sink faucets and shower handrails (steel)) were sampled. Environmental 55 
screening adjacent to one of three ESBL patients yielded ESBL-producing K. pneumoniae from 56 
four out of six sites sampled, which was confirmed using the BD Phoenix automated system for 57 
identification and antimicrobial susceptibility testing (Becton Dickinson, NJ, USA).  K. 58 
pneumoniae was also recovered from the patient’s urine. All environmental isolates and the 59 
patient isolate were resistant to: cefepime, ceftazidime, ceftriaxone, cefuroxime and a 60 
combination of amoxicillin and clavulanic acid.  ESBL production was confirmed by ESBL disk 61 
diffusion phenotypic confirmatory tests using MASTDISC
TM
 (Cefepime-Cefepime/Clavulanic 62 
Acid  ESBL ID Disc Sets, Mast Diagnostics,  UK) performed and interpreted using Clinical 63 
Laboratory Standards Institute (CLSI) guidelines (1). Pulsed field gel electrophoresis (PFGE) 64 
was performed on Xba1-digested genomic DNA from environmental isolates and the patient 65 
isolate using the Pulsenet standardized laboratory protocol for E. coli (9). Analysis of banding 66 
patterns using Bionumerics software (Ver. 6.5, Applied Maths NV, Belgium) indicated that the 67 
isolates were within 90-100% genetically related  68 
Both methods were effective for the recovery of ESBL-PE from high-touch surfaces 69 
adjacent to one of three patients with confirmed ESBL-PE infection. While the contact plate 70 
method was useful for flat surfaces, the Eswab method can be used for irregular surfaces (e.g. 71 
sink faucets).  Four of 18 sites sampled (22 %) were positive for ESBL-producing K. 72 
pneumoniae. All four sites were either adjacent to a single patient with a confirmed ESBL-K. 73 
pneumoniae urinary tract infection or  in the communal bathroom which in this case was also 74 
adjacent to the patient.  Given the low detection limit, low recovery rates and short survival times 75 
(1.5-2h), determined from laboratory testing, the recovery of even small numbers of ESBL-PE 76 
from surfaces suggests a relatively high initial ESBL-PE burden and that the contamination 77 
occurred within a short time prior to sampling.  This was despite routine ward cleaning which 78 
took place less than 3h before sampling.  Furthermore, the recovered isolates were 79 
indistinguishable from the isolate causing the urinary tract infection. This suggests patient 80 
contamination of the environment or vice-versa. Although relatively few studies have confirmed 81 
environmental contamination with ESBL-PE, one recent study carried out over a nine month 82 
period showed recovery of ESBL-PE from 48/370 (4 %) sites, the majority of which were K. 83 
pneumoniae (89 %)(7). Although environmental contamination with  ESBL-PE is not believed to 84 
be as common or extensive as for MRSA and VRE (8), the present findings suggest that 85 
frequently hand-touched surfaces adjacent to ESBL-PE-positive patients and communal 86 
bathrooms, may be an overlooked reservoir for transmission. The poor recovery rates found with 87 
the methods described here, suggest that although these organisms are viable, they may be either 88 
non-culturable or difficult to culture from the environmental setting and more sophisticated 89 
methods are required to recover them. Unlike the recommendations for MRSA/VRE-positive 90 
patients, strict isolation policies are not generally enforced for infections involving ESBL-PE but 91 
as this study reveals, there may be a case for reviewing hygiene measures pertinent to some 92 
ESBL-positive patients.  93 
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Figure 1. Dendrogram showing PFGE profiles for isolates recovered from sites adjacent to an 146 
ESBL-positive patient and the patient isolate causing infection. Pair-wise cluster analysis was 147 
performed using the Dice coefficient with an optimisation of 1% and a band matching tolerance 148 
of 1%. 
a
 isolate recovered using UTI-CTX contact plate, 
b
 isolate recovered using Eswab, 
c
 149 
isolates were from two separate colonies from the original contact plate. 150 
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